ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0000138.1|Rimocidin_1 # 2 # 1897 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.723	BGC0000138.1|Rimocidin_1 	2	1897	+	Loose	700	25.409	vanSE	44.44	3002935	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	ATCACCACCGGGCAGCTCCGGACCGGCGACCGTGACGCCCTCTTCAAGGTCGACTGGACCGGCGTAGCCCTCACGGGCGAGCGCGCGGACTCCCTCGCCCTGCTCGGCAAGGACACCGAAGGCATCCTCGACGGCCTCGCGCTCCAGCCCCGCACGGATCTCGACGACCTCGCGGAGGCAGGCGACCACGACACCGTGCTCGTCCCGCCGATGGCCGGGGGTGCCGGGACGGTGGAGTCCGTTCACGCCGTGGCGGCCGAGGCGCTGGGTGTGATCCAGGCGTGGCTGGCGGATGAGCGGTTCGCGGCTTCGCGTCTGGTGTTCGTGACGCGGGGCGCGGTGTCGGGTGAGGATCTCGCAGGTGCGGCGGTGTGGGGCCTGGTGCGGTCGGCGCAGTCGGAGCACCCGGGCCGCTTCGGCCTGGTGGACGTGGAAGACGACGCCGATGCAGCGCTGATACCGCAGGTATTGGCATCCGACGAGCCGCAACTGCTGATACGCGGCGGCGAGGTGCTGGCGGCGCGCCTGGCCCGTACGGAGGCCCAGCAGCCCCTGGGCTGGGACACCTCCGGCACGGTGTTGATCACCGGTGGTACGGGGGGTCTCGGCCGCATCGTCGCCCGGCACCTGGTGGCGGAGCACGGGGTACGGAGTCTGCTGCTGGTCAGCCGCAGGGGTCCGGCTGCCGAGGGCGCCGAGGAGTTGGTGGCCGAGCTGCGGGACCACGGCGCCGAGGCGGTGGGCGAGGCATGCGACGTAACCGACGCGGCGGCCGTCGCCGACCTCGTTACGCGTCACAAGCCGACCGCTGTGGTGCATACGGCCGGTGTCCTGGACGACGGCGTGGTGGAGTCGCTGACCCCCGAGCGGCTCGCGTCCGTACTGCGCCCGAAGGTCGATGCGGCCTGGAACCTGCACGAGGCGACCAAGGATCTGGTTCTGGACGCGTTCGTGGTGTTCTCCTCCGTGGCCGGCACTTTCGGCAGCGCGGGTCAGGCCAACTACGCGGCCGGTAACGCCTTCTTGGACGCTCTCGCTCACCACCGCCGGACGCAGGGCCTTCCGGCCACGTCGCTCGCGTGGGGCCCGTGGTCCCAGGACAGCGGCATGACCGGCACCCTCACCGACGCCGACGTCCAGCGCATGGCCCGCTCGGGCATGCCGCCGCTGTCGGCCGAGGAAGGCGTGGCGCTGTTCGACGCGGCCCTCGCCAGTGGGGAGCCCGCGACCGTGCCCGCTCGCCTCGACCTGGCGGCCCTGCGCCGGCAGGGCGAGGTGGTCCCGCTGCTGCGCGGCCTGATCAGGACCTCGGGCCGGCGTACGGCGGCGGCCGCGACCGACGGCGACGCCGCGGCCGCCTTCGCCCAGCGGCTGACCGGCCTGTCGGCGGCGGAAGGACGCGAGGTCGTCCTCGATGCCGTACGCGGCCAGGTCGCGGCCGTTCTGGGACACGGCGGGGCCACGGAGATCGATGAGGACCGTGCCTTCCTGGACCTCGGTTTCGACTCCCTCACCGCGGTCGAACTCCGCAACCGGCTGAGTGCCCTCACGGGAATCCGCCTGCCGGCGACGCTGCTGTTCGACTACCCGACGCCGGCGGAACTCGTCGACCACCTCCAGGCCCGCATCGCACCCGAGCCGTCCTTCGGCCCGGAAGCGCTCCTGGGCGAACTCGAAAGGCTGGAGAAGGGCTTCGGTGAACTCGTCATCACCGAGGAGGTGCACGAGCAGATAGCCGGCCGCCTGGAAGTCCTCCGGGCGAAGTGGCAGGCCCTGCGGGACACGGCCCCGGCGGCCGGGCGCGACGGCTCCCCGGCCGACGAGGACTTCGACTTCGAGTCCGCCTCCGACGAGGAGGTCTTCGACCTCCTCGACAACGAACTCGGCCTGAACTGA	ITTGQLRTGDRDALFKVDWTGVALTGERADSLALLGKDTEGILDGLALQPRTDLDDLAEAGDHDTVLVPPMAGGAGTVESVHAVAAEALGVIQAWLADERFAASRLVFVTRGAVSGEDLAGAAVWGLVRSAQSEHPGRFGLVDVEDDADAALIPQVLASDEPQLLIRGGEVLAARLARTEAQQPLGWDTSGTVLITGGTGGLGRIVARHLVAEHGVRSLLLVSRRGPAAEGAEELVAELRDHGAEAVGEACDVTDAAAVADLVTRHKPTAVVHTAGVLDDGVVESLTPERLASVLRPKVDAAWNLHEATKDLVLDAFVVFSSVAGTFGSAGQANYAAGNAFLDALAHHRRTQGLPATSLAWGPWSQDSGMTGTLTDADVQRMARSGMPPLSAEEGVALFDAALASGEPATVPARLDLAALRRQGEVVPLLRGLIRTSGRRTAAAATDGDAAAAFAQRLTGLSAAEGREVVLDAVRGQVAAVLGHGGATEIDEDRAFLDLGFDSLTAVELRNRLSALTGIRLPATLLFDYPTPAELVDHLQARIAPEPSFGPEALLGELERLEKGFGELVITEEVHEQIAGRLEVLRAKWQALRDTAPAAGRDGSPADEDFDFESASDEEVFDLLDNELGLN	MKNNLTVQITKKYFYTMIIITTILVILPLVAKMFLSLRVWQGTEFFYPILYILNRSLGVWLIVTPLFIWLIVTYMFFRKMISYLEEMIVATKSLIETPNEKIVLRVELAEFENEINHIRIDSLENKKMAEEAGKKRDDLLTYLAHDLRTPLTSIIGYISLLQNEQTYLELDSTKRKNYIDIISDKANRLEHLLNDFFEIAKTGKSREEVYKEEVDLSLMLSQISSEFLPLLDEKKLEWDFKIEPNVFVQLNINKFERVLDNLIRNAISYSLNDTTIKLTLEKVDEKVVVSVGNITDKVSEKDIDQLFEPFYRGDKSRNTKTGNAGLGLAIAKQIISEHGGTIEAELQNNDFKVSIIL	176.75	gnl|BL_ORD_ID|1477|hsp_num:0	1571		
BGC0000138.1|Rimocidin_2 # 2006 # 3133 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.722	BGC0000138.1|Rimocidin_2 	2006	3133	-	Loose	1300	28.4906	vanTG	43.75	3002972	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGAACTCACCATCCACGGCGGCCGTGCAGACCGCCCGCCGCATCGCCGTGTCGTTCGTCGCCACCGTTTCGGCCGTGGGGGTCACCGCGTCCTTCGCCTCGGCCGAGCCCGTCGCCGCGCCGCACACCGAAGCGGGACGGCACGCGGCGCAGGCGCCGCGTGCCACGCGCGGGATTCCGTTCACCCAGGCCACGGTGGCCCGACAGCAGGACGGTTCCTTCACCGTGTCCTGGAAAGCGCCCGGCGCCGGTTCCGTGACCGTCTACGCCGACGGCAAGGTCGTGGCATACGGCGGGGCCGAGGCCACCATCACCGTACGCCGGCTGCCCGCGGCCGACCGTCAGTGGTTCCGCCTCGTGCCGGACGAGGGCGACCCGCTCACCCTCGCCGACCGCTCGCTGCACCTGGAGGGCGCCGCCAACTTCCGTGACGTGGGCGGCTACCGAACCGCCGACGGCCGGTGGGTGAAGATGGGCGTGCTGTACCGCTCGCCGACGCCCTGCACAAGCTCACCGACGCCGACCTGGATCAAGCTGCGGCGCCTGGGCATCCGTACGGACTTCGACCTGCGCACGCCGGGCGAGCGGGCCAAGGCCCCGGACCGGGTACCGGCGGGCGCACGCTATGTCGTCGCCAATGTCATCGGCGAGGAGAACTCCGCCGAACTGCCCCCCACGGCGGAGGCGTCCGAGCGGCTGATGGCCGAATCCTACCGGCAGTTCGTCGTCAGGCCCTCGGCCGCCAAGGCTTACCGTTCGCTGTTCCGCATGGCCGCCGAGCCCGGCTCGTACCCGCTGCTCTATCACTGCTCCAGCGGCAAGGACCGCACGGGCTGGGCGACGGCCGTCCTCCTCACGGCCCTCGGCGTGGACCGCGAGACGGTCATGCGCGACTACCTGGCCAGCAACGACTATCTCGCCGCAAGCAACGCCGCCGAACTGGCCAAGCAGCCGCCCGAGATCGCCGCCCGCCTCAAGCCGGTCCTGGAGACCAGGGCCCCGTACCTGAACGCCGCCTTCGACGAGGTCGAGGCGCGCTTCGGCACCTTCGGCGCCTATCTGCGGGAGGGGCTGGGGCTGAACGCGCAGGAGCTGGAGCGGCTGCGGGCGGCGCTGCTCACCGACTGA	MNSPSTAAVQTARRIAVSFVATVSAVGVTASFASAEPVAAPHTEAGRHAAQAPRATRGIPFTQATVARQQDGSFTVSWKAPGAGSVTVYADGKVVAYGGAEATITVRRLPAADRQWFRLVPDEGDPLTLADRSLHLEGAANFRDVGGYRTADGRWVKMGVLYRSPTPCTSSPTPTWIKLRRLGIRTDFDLRTPGERAKAPDRVPAGARYVVANVIGEENSAELPPTAEASERLMAESYRQFVVRPSAAKAYRSLFRMAAEPGSYPLLYHCSSGKDRTGWATAVLLTALGVDRETVMRDYLASNDYLAASNAAELAKQPPEIAARLKPVLETRAPYLNAAFDEVEARFGTFGAYLREGLGLNAQELERLRAALLTD	MTKNESYSGIDYFRFIAALLIVAIHTSPLSSFSETGNFIFTRIVARVAVPFFFMTSGFFLISRYTCNAEKLGAFIKKTTLIYGVAILLYIPINVYNGYFKMDNLLPNIIKDIVFDGTLYHLWYLPASIIGAAIAWYLVKKVHYRKAFLIASILYIIGLFGDSYYGIVKSVSCLNVFYNLIFQLTDYTRNGIFFAPIFFVLGGYISDSQNRLSLKRSIVGFIVCFALMFGEALTLHHFDIQKHDSMYVLLLPSVYCLFNLLLHFRGKRRTGLRTISLIIYIIHPFMIVVIRLFAKLLHLQSLLVENSLVHYIAVCFASVVLAVVITALLSSLKPKKAKHTADTDRAYLEINLNNLEHNVNTLQKAMSPKCELMAVVKAEAYGHGMYEVTTYLEQIGVSSFAVATIDEGIRLRKYGISSEILILGYTSPSRAKELCKYELTQTLIDYRYSLLLNKQGYDIKAHIKIDTGMHRLGFSTEDKDKILAAFSLKHIKVAGIFTHLCAADSLEENDVAFTNKQIGSFYKVLDWLKSSGLNIPKVHIQSSYGLLNYPELECDYIRVGVALYGVLSSTNDKTKLELDLRPVLSLKAKVVLIRKIKQGESVGYSRAFTATRDSLIAILPIGYADGFPRNLSCGNSYVLIGGRQAPIVGKICMDQLAVDVTDIPNVKTGSIATLIGKDGKEEITAPMVAESAESITNELLSRMGHRLNIIRRA	52.67	gnl|BL_ORD_ID|1468|hsp_num:0	1561		
BGC0000138.1|Rimocidin_3 # 3375 # 5024 # 1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.684	BGC0000138.1|Rimocidin_3 	3375	5024	+	Loose	275	25.409	AAC(6')-IIb	40.0	3002595	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	GTGATCGAGAACCAGCACCTGTCACGGCGCCGTCTGCTCGGACTGGCCGCCCTCGGCGGCGCCGCCGTCGCCGGAATGACCACGATTTCCGTCGCCCCGCGCGCCGCGGCCGCCGGGCAGGGAAGCCCGCGGGCCGGTGACGGCGCGTTCGTACCGGCGGTGGTGATCGGCACCGGTTACGGTGCGGCGGTCTCCGCGCTGCGGCTCGGCGAGGCGGGAATTCCGACGCTCATGCTCGAAATGGGCCAGCTGTGGAACAAGCCGGCCGACGACGGCAACATCTTCTGCGGAATGCTCAAGCCCGACCGCAGGTCCAGCTGGTTCAAGTCGCGCACCGAAGCCCCGCTGGGCTCGTTCCTGTGGCTGGATGTCATCAACCGCAACATCGACCCGTACGCGGGCGTCCTCGACAAGGTGCACTTCGACGAGATGTCGGTGTACGTGGGACGGGGCGTCGGCGGCGGCTCGCTGGTCAACGGCGGCATGGCCGTCGTACCGAAGCGCTCGTACTTCGAAGAGGTCCTCCCACGGGTGGACGCCGCCCAGATGTACGACCGGTACTTCCCGCGCGCCAACTCCATGCTCAAGGTGAACCACATCGACAAGGGGTGGTTCGAGGACACGGAGTGGTACAAGTACGCGCGGGTCTCGCGCGAGCAGGCGGGCAAGGCGGGCCTGAGCACCACCTTCGTCCCCAACGTCTACGACTTCGACCACATGCGGCGCGAGGCGGACGGCACGGCGCCCAAGTCGGCGCTGGCCGGCGAGGTGATCTACGGCAACAACCACGGCAAGCAGAGCCTGGACAAGACCTATCTGGCCGCCGCGCTGGGCACCGGCAAGGTCACCATCGAGACGCTGCACCAGGTCAAGGCGATCCGGCGGCAGCCGGACGGCAGCTATGTGCTGTCCGTGGTGCAGAGCGACGCCGACGGCAAGACCATCGCGCAGAAGGAGATCGGCTGCCGCCACCTGTTCCTCGGCGCGGGCAGCCTCGGCTCCACCGAACTGCTGGTGCGCGCCCGCGACACCGGCACGCTGCCCGAGCTGAACGCCGAGGTCGGCGCGGGCTGGGGCCCCAACGGCAACATCATGACCGGCCGCGCCAACCACGTCTGGAACCCCACCGGGGCCCACCAGTCCTCGATCCCCGCCCTGGGCATCGACGACTGGGACAACCCGGCAGCCCCGGTCTTCGCGGAGATCGCGCCGATGCCGGCCGGCCTGGAGACCTGGGTCAGCCTCTACCTGGCGATCACCAAGAACCCCGAGCGCGGCACCTTCGTCTACGACAAGGCCACCGACCGGGCCAAACTGCGCTGGACCCGGGACCAGAACACCCCCGCGGTCAACGCCGCGAAGTCGCTGTTCGACCGGATCAACAAGGCCAACACGACGATGTACCGCTACGACCTGTTCGGTTCGCAGCTGAAGAACTTCTCCGACGACTTCAGCTACCACCCGCTCGGCGGCTGCGTCCTGGGCAAGGCCACCGACCTCTACGGCCGCGTCGCCGGCTATCAGAACCTCTACGTCATGGACGGCGCGCTCGTGCCGGGCTCCATCGGCGTCAACCCCTTCGTGACCATCACGGCCCTCGCCGAGCGCAACATCGAGCGGATCATCGCGGAGGACGTCAAGGCCGCGTAA	MIENQHLSRRRLLGLAALGGAAVAGMTTISVAPRAAAAGQGSPRAGDGAFVPAVVIGTGYGAAVSALRLGEAGIPTLMLEMGQLWNKPADDGNIFCGMLKPDRRSSWFKSRTEAPLGSFLWLDVINRNIDPYAGVLDKVHFDEMSVYVGRGVGGGSLVNGGMAVVPKRSYFEEVLPRVDAAQMYDRYFPRANSMLKVNHIDKGWFEDTEWYKYARVSREQAGKAGLSTTFVPNVYDFDHMRREADGTAPKSALAGEVIYGNNHGKQSLDKTYLAAALGTGKVTIETLHQVKAIRRQPDGSYVLSVVQSDADGKTIAQKEIGCRHLFLGAGSLGSTELLVRARDTGTLPELNAEVGAGWGPNGNIMTGRANHVWNPTGAHQSSIPALGIDDWDNPAAPVFAEIAPMPAGLETWVSLYLAITKNPERGTFVYDKATDRAKLRWTRDQNTPAVNAAKSLFDRINKANTTMYRYDLFGSQLKNFSDDFSYHPLGGCVLGKATDLYGRVAGYQNLYVMDGALVPGSIGVNPFVTITALAERNIERIIAEDVKAA	MHPGVVTLRPMTEDDIGMLHEWLNRPHIVEWWGGERPSLEEVKEDYRPSALAEEGVTPYIGLLDGTPFAFAQSYVALGSGGGWWEEETDPGVRGIDQSIADSGLLGRGYGTRLVQALVDLLFADPQVSKVQTDPSPNNMRAIRCYEKAGFRKVKVVSTPDGPAMYMLHERPLVNGLRSAA	305.00	gnl|BL_ORD_ID|125|hsp_num:0	140		
BGC0000138.1|Rimocidin_4 # 5254 # 6636 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.670	BGC0000138.1|Rimocidin_4 	5254	6636	+	Loose	700	51.2174	oleD	30.08	3000865	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGGAATCCGCCCGACGGCCGATCCTCTTCGTCAGTCTTCCGGAGGCCGGGCTGGCCAATCCGCTGCTCGTCCTGGCCGAGGAACTCTCCCGCCAAGACGTGCCGGATCTCTGGTTCGCCACCGACGAGCCGCGGCGCGAGGACGTGAAGAAGATTTCGGTGGGGTCTCCGGTGGAATTCGCCTCACTGGGCGAGGTGGTCCCCGAACTGTCGGCCGTGACCTGGGGCGACGAGGTGTACCGGGAAGTCACCCAGTCGTCGCGGTTCAAGGCGCACCGCGCGGTGATCCGGCACTCGTACGTGCCCCGCGCGCAGGAGGAGAAGTTCCAGAAGCTCGCGGCCGTCGTCGACGAGATCCGGCCGGCGCTGATCGTCGTCGACTGCATCAGTTCGTACGGCGTGGAGCTGGCCATGGCGCGGAAGATCCCGTACGTGCTCAGCGTGCCGTTCACCCCGAGCAATGTGCTGACGGCGTTCACCCCCTTCGCCAAGGGCTACACCCCGAAGGACTTCCCCGTACCGCACACGGGGCTGCCCTATCCGATGAATCTCCCGCAGCGGGTGCGCAACATGCTCTTCAAACTGCGGACCCTCGCGATGTTCTGCAACCCCACGATGAGCAAGGTACTGGCCGAGGACAACCGGCGGCGCAAGGCGCACGGGCTCGGGCAGATGAGCCCGATGGCGCGGATCGACCACGCCGATCTGGTGCTGTGCAATTCCATCGCCGAGCTGGACTATCCCTTCGACATTCCGGAGAAGTTCCGGATGGTCGGCACGATGGTGCCGCCCCTGCCGGAGGCGGAGCAGGAGGACGAGCTCTCGCGGTGGCTGGACGAACAGCCCTCGGTCGTCTACGCGGGATTCGGAACCATCACCCGGCTCACCCGGGAACAGGTCCATTCCATGGTCGAGGTGGCCCGCCGGCTCCAGGGGCGGCACCAGGTGCTGTGGAAACTGCCCTCGGGACAGCAGCACCTGCTGCCGCCGAAGGAATCCCTGCCGGACAATCTCCGTATCGAGAACTGGGTCCCTTCGCAGCTCGATGTCCTCGCGCATCCGAACGTGAAGCTGTTCTTCACCCACGCCGGCGGCAACGGCTACAACGAAGGCGTGTATTTCGGCAAGCCGCTCGTGGTACGGCCGCTGTGGGTGGACTGCTACGACCAGGCCGTACGCGGCCGGGATTTCGGCATCAGCCTGACCCTCGACCGGCCCCGGGACCTCGATGTCGACGACGTCGTCGACAAGCTGACCCGAGTGCTCGAAACCCCCTCCTTCCGCGAGAACGCGGAGCGGCTCGGCGCCCTGCAGCGTGCGGCGGGCGGCCGTGCGGCCGCTGCCGAGGTGATCCTCGGACACCCGGCCCTGGCCCGGGCGTAA	MESARRPILFVSLPEAGLANPLLVLAEELSRQDVPDLWFATDEPRREDVKKISVGSPVEFASLGEVVPELSAVTWGDEVYREVTQSSRFKAHRAVIRHSYVPRAQEEKFQKLAAVVDEIRPALIVVDCISSYGVELAMARKIPYVLSVPFTPSNVLTAFTPFAKGYTPKDFPVPHTGLPYPMNLPQRVRNMLFKLRTLAMFCNPTMSKVLAEDNRRRKAHGLGQMSPMARIDHADLVLCNSIAELDYPFDIPEKFRMVGTMVPPLPEAEQEDELSRWLDEQPSVVYAGFGTITRLTREQVHSMVEVARRLQGRHQVLWKLPSGQQHLLPPKESLPDNLRIENWVPSQLDVLAHPNVKLFFTHAGGNGYNEGVYFGKPLVVRPLWVDCYDQAVRGRDFGISLTLDRPRDLDVDDVVDKLTRVLETPSFRENAERLGALQRAAGGRAAAAEVILGHPALARA	MTTQTTPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPVFADKVAATGARPVLYHSTLPGPDADPEAWGSTLLDNVEPFLNDAIQALPQLADAYADDIPDLVLHDITSYPARVLARRWGVPAVSLSPNLVAWKGYEEEVAEPMWREPRQTERGRAYYARFEAWLKENGITEHPDTFASHPPRSLVLIPKALQPHADRVDEDVYTFVGACQGDRAEEGGWQRPAGAEKVVLVSLGSAFTKQPAFYRECVRAFGNLPGWHLVLQIGRKVTPAELGELPDNVEVHDWVPQLAILRQADLFVTHAGAGGSQEGLATATPMIAVPQAVDQFGNADMLQGLGVARKLATEEATADLLRETALALVDDPEVARRLRRIQAEMAQEGGTRRAADLIEAELPARHERQEPVGDRPNGG	110.84	gnl|BL_ORD_ID|1284|hsp_num:0	1367		
BGC0000138.1|Rimocidin_5 # 6690 # 7748 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.662	BGC0000138.1|Rimocidin_5 	6690	7748	+	Loose	750	26.5646	tet(49)	34.04	3004582	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGTCGTTCAAGTATCCCGTGTCCAGGCCCGCTCTGGAGGGCAACGAGCTGGCGTATCTGACCGGTGCCGTCGAGGACGGGTGGATTTCCTCCCAGGGCCCGATGGTCGGGCGGTTCGAGCGTGCCTTCGCCGACTACAACGGCATCGCGCACGGCGTTTCCTGTTCCTCGGGAACGGCGGCGCTCACCCTCGCGCTGCGGGCGCTGGGCATCGGCCCGGGGGACGAGGTCATCGTCCCGGAATTCACGATGATCGCCTCGGCATGGGCGGTCACCTACACCGGCGCCACGCCCGTGTTCGTGGACTGCGGGGACGACCTCAACATCGACGTCACCCGTATCGAGGAGAAGATCACGGCGCGCACGAAGGCCGTGATGCCGGTGCACATCTACGGCCGGCGGTGCGACATGGACGCGATCATGGACATTGCGTACCAGTACAACCTGCGGGTCGTGGAGGACAGCGCCGAAGCGCACGGCATTCGGCCGGTCGGTGACATCGCGTGCTACTCGCTGTTCGCCAACAAAATCATCACGGCGGGGGAGGGCGGTATCTGCCTCACCGACGACCCGAAACTCGCCGGGCAGATGCAGCACTTGCGGGCCATGGCGTTCACCAAGGACCACAGTTTCCTGCACAAGAAGGTGGCGTACAACTACCGCATGACGGCCATGCAGGCCGCCGTCGCGCTCGCCCAGACCGAGCGCCTGGACGACATCCTCGAAGTGCGCCGCGGAATCGAGAAGCGCTACGACGAGGGGCTGGCCGATGTCCCCGGTATCACGCTGATGCCGCCGCGGGACGTGCTGTGGATGTACGACCTGCGCGCCGAACGCCGCGAGGAACTGCGGGAATTCCTGGCCGGGGAGTCCATCGAGACCCGGCTGTTCTTCAAGCCGATGAGCCGGCAGCCCATGTACTTCCACCCCGACTGGCCCTCGCTCAAGGCGAACACCTTCGCCGAGGACGGACTGTACCTGCCCACCCACACCGGACTGACCGCCGGCGACCAGGACTTCGTGATCGACCGGGTCCGCGCCTTCTACGGCGTCGGCTGA	MSFKYPVSRPALEGNELAYLTGAVEDGWISSQGPMVGRFERAFADYNGIAHGVSCSSGTAALTLALRALGIGPGDEVIVPEFTMIASAWAVTYTGATPVFVDCGDDLNIDVTRIEEKITARTKAVMPVHIYGRRCDMDAIMDIAYQYNLRVVEDSAEAHGIRPVGDIACYSLFANKIITAGEGGICLTDDPKLAGQMQHLRAMAFTKDHSFLHKKVAYNYRMTAMQAAVALAQTERLDDILEVRRGIEKRYDEGLADVPGITLMPPRDVLWMYDLRAERREELREFLAGESIETRLFFKPMSRQPMYFHPDWPSLKANTFAEDGLYLPTHTGLTAGDQDFVIDRVRAFYGVG	MSAINKILVIGAGIAGPTVCYWLKRFGFSPTLIERSSKIRKGGQGLDVRGVAIDIVKRMGIYEKICNMRTQVELGRYVDARGNILHEEKGERFAFRQGEDVEINRGDLVEILIQTIEGVPCHFNQWIDGIKQSDNDVEVQFKDGRTEHYGLVIGADGLHSKTRRMVFNEDEYKLTNLGLYFSVFSIPNYLNLNHTEVQFEANQKLISLTSDKNPKMAEAAFCFRTQNVLNNIRDENEQQKFLRDTFQDFGWETSKILELMSDSDNFYFDSVTQVEMKSWTKGRVALLGDAGYSASPISGQGNNLALVGAYVFAGELKQAGGNYHRAFSRYNELLHSFVEANQKLGILVNESTLVYGEVSQEVAEERSNKIMQEVEIAANMISLPNYE	90.96	gnl|BL_ORD_ID|2778|hsp_num:0	3285		
BGC0000138.1|Rimocidin_6 # 7777 # 9039 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.683	BGC0000138.1|Rimocidin_6 	7777	9039	+	Loose	575	28.8758	AST-1	34.21	3004740	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	AST Beta-lactamase	ATGACGCACACCGAACCGGCCGCGCCGGCCACCTGCCCGGTCACGGGAGCGACGGCCGGGGCCACGGACACGACGGATTCGACCGGGCACGGAACGGACCCGCTGGTCGTCGACTTTCCGCTGCGCGCGCCCGGCATACCCTTCCCGCCGCCCGAATACGCCGATTACCGCGACAAGAAGGGGCTGGTGCTCTCGCACCTGCCCGACGGCAAACGGGTGTGGCTGGTCACCCGGCACGAGGACGTACGCGCCGTCCTGACCAACCCGGCCATCAGCTCCAACCCCCAGCACCCGGGCTTTCCCAATGTCGGCGAGACGATCGGCGTACCCAGGCAGGACCAGATACCCGGCTGGTTCGTGGGAATGGACTCGCCCGAACACGACCGGTTCCGCAAGGCCCTCATCCCGGAGTTCACCGTGCGGCGCGTCCGCGCGATGAAACCCGCGATCGAGCGCACGGTGGACGCGCAACTGGACGCGATGCTGGCCGCGGGCAACACCGCCGACCTCGTCGCCGACTTCACCCTGCCCATTCCCTCCCTGGTGATCTCGGCACTGCTCGGCGTGCCGCCCGCCGACCGCGAGTTCTTCGAATCCAGGACCCGCGTCCTGGTCTCGTTCCGTGCGTACTCCGACGAGGACCGCCTGGCCGCCGGCAAGGACCTCATGCGGTACATCAACCGGCTGATCGAGATCAAGAAGAACTGGGGCGGCGACGACATCGTCACCCGGCTGCTGGCCACCGGCGCCATCGGTGCCCACGAAATGTCCGGCGTACTGATGCTGCTGCTCATCGCCGGCCACGAGACCACGGCCAACAACATCGCGCTCGGTGTGGTCACCCTGCTGAAGAATCCCCAGTGGATCGGTGACGAACGGGCCGTCGAGGAAACCCTGCGCTTCCACTCGGTCGCCGACCTGGTGTCCCTGCGGGTGGCCGTCGAGGACGTGGAGATCGCCGGGCAGCACATCAAGGCGGGCGAGGGCATCGTGCCGCTGGTCGCCGCCGCCAATCACGACGAGGAACTCTTCGCGTGCCCCCACGCGTTCGACCCCTCCCGCTCCGCCCGCGGCCATGTGGCCTTCGGCTACGGCGTACACCAGTGCCTGGGGCAGAACCTGGTACGGGTCGAGATGGAGGTCGCGTACCGCAAGCTCTTCGAGCGCATTCCCAACCTCCGGCTCGACGTGCCCGAGGACGGACTGAACATCAAGTACGACGGCGTGCTCTACGGCCTGCACGAGCTGCCCGTCCGCTGGTGA	MTHTEPAAPATCPVTGATAGATDTTDSTGHGTDPLVVDFPLRAPGIPFPPPEYADYRDKKGLVLSHLPDGKRVWLVTRHEDVRAVLTNPAISSNPQHPGFPNVGETIGVPRQDQIPGWFVGMDSPEHDRFRKALIPEFTVRRVRAMKPAIERTVDAQLDAMLAAGNTADLVADFTLPIPSLVISALLGVPPADREFFESRTRVLVSFRAYSDEDRLAAGKDLMRYINRLIEIKKNWGGDDIVTRLLATGAIGAHEMSGVLMLLLIAGHETTANNIALGVVTLLKNPQWIGDERAVEETLRFHSVADLVSLRVAVEDVEIAGQHIKAGEGIVPLVAAANHDEELFACPHAFDPSRSARGHVAFGYGVHQCLGQNLVRVEMEVAYRKLFERIPNLRLDVPEDGLNIKYDGVLYGLHELPVRW	MTFSALPFRRADRRRLLAAALAACALTLTAACDSGTVTVPVTDSVTTSAVADPRFAELETTSGARLGVFAVDTGSGRTVAHRADERFPMASTFKGLACGALLREHPLSTGYFDQVIHYSAAELVEYSPVTETRVETGMTVRELCDAAITVSDNTAGNQLLKLLGGPEGFTASLRSLGDATSRLDRWETDLNTAIPGDERDTTTPAALAADYRALVVGDVLGAPERDQLKAWLVANTTGATRIRAGLPADWTVGDKTGSPAYGSALDVAVAWPPGRAPIVIAVLSTKSEQDAEPDNALLAEATRVVVDALG	135.48	gnl|BL_ORD_ID|2624|hsp_num:0	3555		
BGC0000138.1|Rimocidin_7 # 9125 # 9316 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGGAG/GGAGG;rbs_spacer=11-12bp;gc_cont=0.719	BGC0000138.1|Rimocidin_7 	9125	9316	+	Loose	2000	21.1718	Bifidobacterium adolescentis rpoB mutants conferring resistance to rifampicin	34.29	3004480	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	ATGCGTATCACCGTTGACTCCGACCGCTGCGTCGGGGCGGGCCAGTGCGTACTGAACGCGCCCGCGGTCTTCGACCAGGACGACGACGGGCTCGTCACCCTTCTCGCCGAGCCCGGCGCCGACCAGGAGGCCGCCGCCAAACTGGCCGGTGCCCTGTGCCCGTCCGGGGCCATCACCGTGCACGAGGGCTGA	MRITVDSDRCVGAGQCVLNAPAVFDQDDDGLVTLLAEPGADQEAAAKLAGALCPSGAITVHEG	MAEATTNTTTIIARADQHDIDLHKASDRVNFGSIREPIDVPYLLGVQTDSFDWLIGNERWQKRVQEDLENGTNTVPHTSGLDEVFQEISPIENFAQTMSLTFSDPYFEEPRHTVQECKEKDYTYSAPLYVNAEFENGDTGEIKSQTVFMGDFPLQTPHGTFIIGGTERVIVSQLVRSPGVYFDRSQDRTSDKEVFGAKIIPSRGAWLEFEIDKRDVLGVRVDRKRKQSAIVFLMAIGMTKDEIADAFKDYPLVMDALAKETVQTQDEALTDLYRKIRPADTPTPEAGKNLLDSFYFNTKRYDLARVGRYKINRKLGLEKDVNDRSLSREDIIATIKYLVTLHAGETKFPGKRDGQDVDLRVDVDDIDHFGNRRIRQVGELIQNQLRTGLSRMERVVRERMTTQDPEAITPQSLINIRPVNATIKEFFGTSQLSQFMDQNNPLAGVTNKRRLSALGPGGLSRDRASMEVRDVHPSHFGRMCPIESPEGPNIGLIGSLATFGRINPFGFIETPYRKVVNGHVTDEVEYMTADRDAEHVIAQANQELDENGNFVKKQALARVGEEEAVDVPVSSVDYMDVSPRQMVSVGASLIPFLEHDEGHRALMGTNMQRQAVPLIESERPLVGTGAEWRAAVDSGDVILAEKPGVVTYVSADIIRTMNDDGTTSSYKLAKFQRSNQTTCYNQVPLIHDGERVEAGTVLADGPATQKGEMALGKNLLIAFMPWNGYNYEDAVIISQRLVQDDTLSSIHIEEYEIDARETKLGAEEITRDLPNVGEDAVANLDERGIIRIGAEVEAGDILVGKVTPKGETELTPEERLLRAIFGEKSREVRDTSLRVPHGETGTVIAVKEITREDAEEDGDELPNGVNQMIRVYIAQHRKITQGDKLSGRHGNKGVISRILPEEDMPFLADGTPVDIMLNPLGVPSRMNLGQVLELHLGWIAHAGWDISLDPDAEAAWKKYVPQGAEKGAPGTPVATPVFDGVRPETIKGLLSCTLPDRDGNKLVGPDGKATLFDGRTGEPFPKPISVGYMYMLKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMEVWALEAYGAAYTLHEMMTTKSDDVDGRVRVYGAIVKGENLPPAGIPESFKVLLKEMQSLSLNVEVLNADGVAIDMKEEDDDPSTSSDDLGFNIGARPDAAAKEDQVAEEPEFQ	5.31	gnl|BL_ORD_ID|2668|hsp_num:0	2914		
BGC0000138.1|Rimocidin_8 # 9400 # 14610 # 1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.750	BGC0000138.1|Rimocidin_8 	9400	14610	+	Loose	950	28.8758	msrE	35.0	3003109	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	GTGCCCGTCCACACAGCTGACTACGTGATCCAGCCGCCCACCGACGCGGCGGAGGTACGGGGCGGCCACACGCTGCCCGAGGTGTTCGAGACCGCGTCGAGGGCCGCCCCCGACGCGGTGGCCATCGTGGACGGGGACCGTTCGCGGACCTGGGCGCAGTGGCGGGCGGACGTCCGCGCGCTGGCCCGTGGCCTCCAGGAATCGGGCGTCGGGCCCGGTGACGTGGTGGCGGTGCGGCTGCCGAACAGCTGGGAGTTCCAGACCCTGCACCTGGCCGTCGCGGCCGTCGGCGCCGTACTGCTGCCCGTCCACGAGGGCACCCCGACCGCGGAGGTCCACGCGCTGCTGACCCGCGCGGAACCCGTACTCCTCGTCCTGTCGGCTTCCGGGAGCGAGGGCACGGCAACGGCCCGCTCGCTCCTGGAGAGCGTGCCGACGCTGCGCGGCGTGCTGCTGGCCGGGGCGTCGGAGGCGGAGTGCGAGGAGCCGGGGATCGGGGCGCTGGACGGGTTGCGGGCAGCCTGGACGGGCAGCGAGCCCCGGCCGGTGCACCTCACCCCCGACATGCCGCTCGCCCTGATCCCCTCGTCCGGCACCACCTCGGCGCGGCCCAAGCTGTGCGTGCACACCCACGGCGGCCTGCTGGCGAACACCGCGGCCGTCGTGGCCGATGCCGCCGACGCCTTCGGCGGCACGGTCCTGACCGCCTGCCCGATGACCCACCTGTTCGGGCTCCAGTCCCTGCACACGGCGCTGTTCGCCGCCCGGACGCAGGTCCTGCTCACCGGCTGGGACGTGGACCGCTTCCTGGAGCTGGCGCGGGAGCACAACCCCCGCGTCGTCTTCGCCGTACCCGCCCAACTGCGGGACATCGTCGCGCGACTCGCCAGGGCGGGCGAGCCGGCGGGCTTCGCGCCGCACCAGGTGCGTACGGCGGGCGCCGCCCTCGCACCCGCGCTCGCCGCACAGATACGCGCCGCCCTCGACTGCGAACCGGTCGTGGTGTGGGGCATGTCCGAGATCGGCACCGGCACCGCAACCCGGGCCCACCACCCCGACGGCAGCGTGGGAGAACCGGTCGACGGCGTGCGCGTACGGGTCGTCGACGAGCACGGCGCGGAGTGCGCGGCGGGGGAGACGGGCGAGCTCCAGTACCAGGGCCCGGCGATGTTCCGCGGCTATTTCCGCGAGCCGGAGCTGACGCGCTCGGCCCTCACCGACGACGGCTGGCTGCGGACCGGCGACATCGCCGCCATCGACGCGGACGGCGTGGTCGTCCTGCACGGCCGGGCGGCCGAAGTGATCGCCACCGGAGGCCGGAAGTTCGGCGCCACCGAAATCGAGAGCCTGCTCGCGGAGCTCGCGGGCCTGGGCCCGCTGGCCGTGGCGGGGGCGCCGGACGACCGGCTCGGCGAGTACCCGTGCCTGGTCGTGACCGACCGCGCGGACCGTACGATCGGGCTGACCGAGGTGACCGCGTTCCTGCGCCGGCGGGGACTCGCCGACCACAAGATCCCCCTCGAACTGGTCACCGTGCGCGAGCTGCCCTTCACCCCCGCGGGGAAGCTCGACCGCAGGGCACTCAAGGAGCAGCTGCGCACCGGCCTGGAAGCGACGCCCGTGGCGGCCCGTCTCGGCGCGGTCCCGCCGGAGACGGCCGAAGAGGCGCTGGAACTGGTACGCGACTGCGTCGGCCAGGTCCTCGGCAGCAGCGGCGACCCGGCCGGCCCCGCCGTCGGTGCGCCGGAATTCCCCGACACCGAATTCCGCCGGCTCGGCCTCGACTCCGTCCTCGCGGTGCGGCTGCGCAACCTGCTGCGGGAGGAGACCGGGCTGTCCCTCCCGGTCACGCTGGCCTTCGACTTCCCGACGCCGCGGGCCGTGGCGCACGCACTGGCCGAGCAGAACGACCCGGCTTCGGCGGCGGCATCGGGGAAGACGGCGGAGGAGGCGCGGAGGTTCCCGGCCGACGAGGCCGATCCGGTGGCGATCGTCGCCATGGCCTGCCGCCTGCCGGGCGGCGCCGACTCTCCCGACGCCCTGTGGGAGCTGCTGGCCGGCGGAACCGACGCGATGCGGCCCTTCCCGGACGACCGCGGCTGGGACCTGGACCGCCTCTTCGACGAGGACCCCGACCGGCCGGGCACCTGCTACGCACGCGAAGGCGGCTTCCTGCCCGGCGCGGGCGACTTCGACGCGGGCTTCTTCGGCCTGTCCGACCACGAGGCGACGGCCACCGACCCGCAGCAGCGCCTGCTCCTGGTGGCGGCCTGGGAGACCTTCGAGCGGGCGGGCATCGACCCGGCGTCCCTGAAGGGCACCCGTACGGGCGTGTTCACCGGCGCGATGGAGCGCGGCTACGGCGCTCTCGCGTCCGCCGTCCCCAGCGAGTGGGAGAGCACGCTCACCACCGGGGCCGCCAACAGCGCGATCTCCGGGCGCATCGCCTACACCTACGGCCTCGAAGGCCCCGCGCTGACCGTCGACACCGCCTCCTCGTCCTCCCTCGTCGCCCTGCACCTGGCCTGCCGCTCCCTGCGGTCGGGCGAGACCGACCTGGCGCTGGCCGGCGGCGTCACCGTCATGGCGACCCCGGCGCCCTTCACCCACTTCGCCCGGCTGCGCGCGCTCGCCACCGACTCGCGCGCCAAGGCGTACGCGGACACCGCGAACGGCTCCGCGTGGGCGGAAGGCGCGGGACTGCTGCTGCTGGAGCGGCTGAGCGACGCCCGCCGCAACGGACACCGTGTACTGGCGCTCGTACGGGGCTCGGCGGTCAACCAGGACGGCGCCTCCAACGGGCTCACCGCCCCGAGCGGCCCCGCGCAGCAGCGCGTCATCCGCCAGGCCCTGGCCGACGCCGGTCTGACGCCGCGGGACGTGGACGCGGTGGAGGGGCACGGCACCGGCACTCCGCTCGGCGACCCGATCGAGGCCCAGGCCCTGATGGCCACCTACGGCCAGGAGCGGCCGGAGGGACGGCCGCTGTGGCTGGGGTCGGTGAAGTCCAACCTCGGGCACACACAGGCCGCTGCCGGGGTCGTCGGGGTCATCAAGACGGTGCTCGCGCTGGGCCGCGGCGTCCTGCCCAGGACGCTGCACGTGGAGACTCCTTCCACCAAGGTCGACTGGTCCGCCGGGGCGGTACGGCTGCTGACCGAGGCGCAGCCCTGGCCCCAGGAGAGCGGGCACACGCGGCGGGCAGGAGTGTCGTCCTTCGGGCTCACCGGCACCAACGCCCACGTGATCCTGGAGGAGGCCCCGGACGGGACGCAGAGCGCGCCCGGATCGGAACCGGCCGACGACACCGCCGTACCGTGGGTGCTCTCCGCACGGAGCCGGACGGCGCTGCGCGAACAGGCCCGCCGCCTGGCCGAGCACGTGACCGCTCACCCCGGCCTGCGCACACAGGACATCGCCCACGCCCTGGCCACCACCCGCACCCGGCACCGGCACCGGGCCGTCGTCAGCGGCTCCGACCGGGACCGGATGCTGTCCGCGACGGCCGCGTTCGGGCGCGGGGAGCGGGCCGCGGACGTCACCCCGCTCGATTCCGCGCCGGGCGGCCTGGCCTTCGTCTTCTCCGGACAGGGCGGCCAGCACCCCGGCATGGGGCGCGGGGCGGCCGAGGCGTTCCCCGTGTTCGGGGAGGCGCTGCGCGAGGTGTGCGACACCCTCGACCCGCTGCTGGCACGTCCGCTGACCTCGGTGATGTGGGCGGACGCCGACTCCGAGGAGGCGACGCTGCTGCACAACGCCGAGTTCTCGCAGCCCTCGCTGTTCGCCCTCCAGGTCGCCCTCTACCGGCTGTACGAGTCCTGGGGCATGGCCCCGGACCGTCTCGCGGGCCATTCGGCCGGCGAGATCGCCGCCGCGCATGTCACCGGCATCCTCACCCTCCAGGACGCCTGCGCCCTGGTGGCCTCCCGGGGCAGGCTGATCAGCTCGCTGCCGGTCGGCGGCGCGACGGTGGCGGTGCGCATCTCGGAGGACGAGGTGCGGGGGTGGCTCGCCGAGGAGACGACCGGCTCGGTCTCGATCGCGGCCGTCAACGGGCCGCACTCCCTCGTACTCTCCGGTGCCGAGGCCCCGCTCATCGCCCTCACGGACCGGCTCCGCGACGCCGGCCACAAGACCCACCGCATCCCCATGAGGGTCGCGGCCCACTCACCGCTGATGGACCCCATCCTGGGGGAGTTCCGCGCGGTCGTCCGCACGCTGGCCTACGGCACGCCCACCATCCCCCTCGTCTCCACCGTCACCGGCCGCCCGCTGACCGACGAGGAGGCGCGCGACCCTGAGCACTGGGTACGGCACGTGCGGCGGCCCGTGCGCTTCAAGGACGCGATCGGCCGGCTCCGGGAGGAGCGCGTCACCGGCTTCCTGGAGCTGGGCGCCGAGCCGCTGCTCACCCCCATGATCGACGAGTGCCTGGAGGCGGCCGGCCCGCAGCACGGAACCGCCGTGGTGCCGAGCCTGAGCTCCGGCGTACCGGACCGGCAGATCCTGCTCTCCGCGGCCGCCCGGGTGCACACCCACGGCGCACCCGTCGACTGGGACGCGGTGCTGCCCGGGGCCCGGCCCGTCGACCTGCCGACGTACGCGTTCCAGCGGCGGCGGTTCTGGCTGGCGGCGGGGCCGGGTGCGGCCGCCGAGGCCGGTTTCGTGGGTGCCGCGATCGGCGCGGGCGCGCCGGCGGCCGATGCGGAGGAGCCGTCGGGCCTGGAAGCCCGGCTGGCCGGTCTCGAAGACGCCGAACAGGACGCGTACGTACGCTCCCTGGTGCTCGCCGAGACCTCGGCCGTGCTCGGCGGCCAGGAACCGCTCGACAGCGAAGGCACCCACACCTTCAAGGAGATGGGCATCAACTCGGTGAACGCCGTCGAGCTCCGCAACCGCCTCATCGCGGCCACGGACCTGCGGCTCCCCGCCACGCTCGTCTACGACCACCCCACCCCGAACGCGGTCGTCCGCCTCGTACGCGAACGCCTCGCGCGCCCGGCCACCGCCGCACGCGACGTGGACTCGGTCGTGGCCGAGCTGGAGTCCCTGCTCACGGCCGGCGCGGAGGTCTCGGCGGAGGCGGTGGCACGGCTGAAGGCGATGGCGGCGGGGCGGGACGGCACTACGGACACCGGTTCCGGCGGGCCCCTGGACCTGACGTCGGCCAGCGACGAGGACCTGTTCCGGCTGATGGACGCGGAGCACTGA	MPVHTADYVIQPPTDAAEVRGGHTLPEVFETASRAAPDAVAIVDGDRSRTWAQWRADVRALARGLQESGVGPGDVVAVRLPNSWEFQTLHLAVAAVGAVLLPVHEGTPTAEVHALLTRAEPVLLVLSASGSEGTATARSLLESVPTLRGVLLAGASEAECEEPGIGALDGLRAAWTGSEPRPVHLTPDMPLALIPSSGTTSARPKLCVHTHGGLLANTAAVVADAADAFGGTVLTACPMTHLFGLQSLHTALFAARTQVLLTGWDVDRFLELAREHNPRVVFAVPAQLRDIVARLARAGEPAGFAPHQVRTAGAALAPALAAQIRAALDCEPVVVWGMSEIGTGTATRAHHPDGSVGEPVDGVRVRVVDEHGAECAAGETGELQYQGPAMFRGYFREPELTRSALTDDGWLRTGDIAAIDADGVVVLHGRAAEVIATGGRKFGATEIESLLAELAGLGPLAVAGAPDDRLGEYPCLVVTDRADRTIGLTEVTAFLRRRGLADHKIPLELVTVRELPFTPAGKLDRRALKEQLRTGLEATPVAARLGAVPPETAEEALELVRDCVGQVLGSSGDPAGPAVGAPEFPDTEFRRLGLDSVLAVRLRNLLREETGLSLPVTLAFDFPTPRAVAHALAEQNDPASAAASGKTAEEARRFPADEADPVAIVAMACRLPGGADSPDALWELLAGGTDAMRPFPDDRGWDLDRLFDEDPDRPGTCYAREGGFLPGAGDFDAGFFGLSDHEATATDPQQRLLLVAAWETFERAGIDPASLKGTRTGVFTGAMERGYGALASAVPSEWESTLTTGAANSAISGRIAYTYGLEGPALTVDTASSSSLVALHLACRSLRSGETDLALAGGVTVMATPAPFTHFARLRALATDSRAKAYADTANGSAWAEGAGLLLLERLSDARRNGHRVLALVRGSAVNQDGASNGLTAPSGPAQQRVIRQALADAGLTPRDVDAVEGHGTGTPLGDPIEAQALMATYGQERPEGRPLWLGSVKSNLGHTQAAAGVVGVIKTVLALGRGVLPRTLHVETPSTKVDWSAGAVRLLTEAQPWPQESGHTRRAGVSSFGLTGTNAHVILEEAPDGTQSAPGSEPADDTAVPWVLSARSRTALREQARRLAEHVTAHPGLRTQDIAHALATTRTRHRHRAVVSGSDRDRMLSATAAFGRGERAADVTPLDSAPGGLAFVFSGQGGQHPGMGRGAAEAFPVFGEALREVCDTLDPLLARPLTSVMWADADSEEATLLHNAEFSQPSLFALQVALYRLYESWGMAPDRLAGHSAGEIAAAHVTGILTLQDACALVASRGRLISSLPVGGATVAVRISEDEVRGWLAEETTGSVSIAAVNGPHSLVLSGAEAPLIALTDRLRDAGHKTHRIPMRVAAHSPLMDPILGEFRAVVRTLAYGTPTIPLVSTVTGRPLTDEEARDPEHWVRHVRRPVRFKDAIGRLREERVTGFLELGAEPLLTPMIDECLEAAGPQHGTAVVPSLSSGVPDRQILLSAAARVHTHGAPVDWDAVLPGARPVDLPTYAFQRRRFWLAAGPGAAAEAGFVGAAIGAGAPAADAEEPSGLEARLAGLEDAEQDAYVRSLVLAETSAVLGGQEPLDSEGTHTFKEMGINSVNAVELRNRLIAATDLRLPATLVYDHPTPNAVVRLVRERLARPATAARDVDSVVAELESLLTAGAEVSAEAVARLKAMAAGRDGTTDTGSGGPLDLTSASDEDLFRLMDAEH	MSLIIKARNIRLDYAGRDVLDIDELEIHSYDRIGLVGDNGAGKSSLLKVLNGEIVLAEATLQRFGDFAHISQLGGIEIETVEDRAMLSRLGVSNVQNDTMSGGEETRAKIAAAFSQQVHGILADEPTSHLDLNGIDLLIGQLKAFDGALLVISHDRYFLDMVVDKIWELKDGKITEYWGGYSDYLRQKEEERQHQAVEYELMMKERERLESAVQEKRQQANRLDNKKKGEKSKNSTESAGRLGHAKMTGTKQRKLYQAAKSMEKRLAALEDIQAPEHLRSIRFRQSSALELHNKFPITADGLSLKFGSRTIFDDANFIIPLGAKVAITGSNGTGKTSLLKMISERADGLTISPKAEIGYFTQTGYKFNTHKSVLSFMQEECEYTVAEIRAVLASMGIGANDIQKNLSDLSGGEIIKLLLSKMLLGKYNILLMDEPGNYLDLKSIAALETMMKSYAGTIIFVSHDKQLVDNIADIIYEIKDHKIIKTFERDC	353.56	gnl|BL_ORD_ID|27|hsp_num:0	33		
BGC0000138.1|Rimocidin_9 # 14688 # 16367 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.702	BGC0000138.1|Rimocidin_9 	14688	16367	-	Loose	500	25.409	mphA	42.86	3000316	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	ATGTCGATGCGTCCGAGTGGGCCGGGGGAGATTCCGGCGGAGACGGTGCGGGTGGCCCGGGCGGCGTTTGCGAAGGGAAGCCTGGCGATCCGGGTCCGGGACGAGCTGGGGCCGATGTTCCGGGACGAGGACTTCGCGGATCTGTTCGCCTCACGAGGCCGGCCTGCCTGGTCTCCGGCCGGTCTGGCGCTGGTGTCGGTGCTCCAGTTCGTGGACGGGCTGACCGACCGCCAGGCCGCGGAAGCGGTGCGGGCGCGGATCGACTTCAAGTACGCCCTCGGGCTGGAACTGGGCGATCCCGGCTTCGACTTCTCGGTGCTGTCGGAGTTCAGGGACCGGCTGGCCGGGGCCGATGGAGGGCGCCGGGTCATGGACGGTGTGCTGGTGGCAGCCCGCGAGAAGGGGCTGCTCAAGAGCGCGGGCCGGGCCCGCACCGACTCCACGCACATCTTGTCCTCGGCACGGCAGCTGAACTGGCTGGAGCTGGTCGCGGAGACGCTGCGATCGGCTCTGAACGCACTGGCCCAGGCTGCCCCCGGCTGGCTGGCCGAAGCCGCCGAGCCGGACTGGTTCCGGCACTACGCGACCCGGGCCGAGGAGTCCCGGTTCCCCAAGGGCCGTGCCAGGCGGGACGAGGTGGGCCTGCGGATCGGCAGGGACGGGATGCGGCTGCTGGAGGAGGTCTTCGCCACCGTTGCACCGCACCGGCTTCGCGCACTCGATGAGGTGGAGATCCTGCGGCAGGTCTGGGTCCAGCACTTCCACATGGTGGAGGGCGAGGTGGCCAGGCGGGACCCAAAAGACCGTCCGCCGGGCATGATGCGCCTGGTCACCCCGTATGACCGCGAGGCCCGTGGCAGCGTGAAGCGGGACATCATGTGGGACGGCTACAAGGTCCATCTCACCGAGATCTGCGAGGCGGACGCCCCGAACCTGATCACGAACGTGGCCACCACCGTCGCCACCGTCTCGGACAGCGTGATGAGCCAGTCGATCCACGCGGGCCTCGCCGACCGCGACTGCCTGCCCGGCGAACACTGGGTCGATGCCGGTTATCCCACCGCCACTCAAGTCCTGGCCGCCCGCACCGAGCATGGCGTCGCGCTGCACGGGCCCATGGCTGCCAACACGTCCGCCCAGTCCGCGGGCCCCTACGGCCTGGACGCATTCACCGTCGACTGGGACCAGCAGCAGGTGGCCTGCCCCGGCGGCGTCACCACGACCCAGTGGTATCCGCGCACGGACTCCAAGGGCCTCGCGGTCATCCGCGTGCGGTTCCGCCACAGCGAGTGTCGCCCCTGTCCCCACCGGCACGAGTGCGTGGGCTCGGCTACCGGCCAGCGCCGGGAGATCATGCTGCGTCACCGGGAGGAACACGAGATCATCCGACACAGCCGCGCCGAGCAGCAAACCGATGCCTGGAAGGACCGTTACAAGATCCGTGCCGGGGTCGAGGGCAGCATCTCCCAAGCAGTCGGGCGCTGCGGCCTGCGCAGATCCCGCTACCGGGGCCTGACAAAGACCAGCCTCCAGCACCAGCTCACCGGAGCCGCGATCAACCTTGCCCGCATCGACGCCCACCTCACCGGCACACCCCGAGCCCGCACCCGCACCAGCCACTTCGCAGCACTGTGCCCCGCCGAGATGACGCTCGACGGGGCACAAGCAGGGACCGAATAA	MSMRPSGPGEIPAETVRVARAAFAKGSLAIRVRDELGPMFRDEDFADLFASRGRPAWSPAGLALVSVLQFVDGLTDRQAAEAVRARIDFKYALGLELGDPGFDFSVLSEFRDRLAGADGGRRVMDGVLVAAREKGLLKSAGRARTDSTHILSSARQLNWLELVAETLRSALNALAQAAPGWLAEAAEPDWFRHYATRAEESRFPKGRARRDEVGLRIGRDGMRLLEEVFATVAPHRLRALDEVEILRQVWVQHFHMVEGEVARRDPKDRPPGMMRLVTPYDREARGSVKRDIMWDGYKVHLTEICEADAPNLITNVATTVATVSDSVMSQSIHAGLADRDCLPGEHWVDAGYPTATQVLAARTEHGVALHGPMAANTSAQSAGPYGLDAFTVDWDQQQVACPGGVTTTQWYPRTDSKGLAVIRVRFRHSECRPCPHRHECVGSATGQRREIMLRHREEHEIIRHSRAEQQTDAWKDRYKIRAGVEGSISQAVGRCGLRRSRYRGLTKTSLQHQLTGAAINLARIDAHLTGTPRARTRTSHFAALCPAEMTLDGAQAGTE	MTVVTTADTSQLYALAARHGLKLHGPLTVNELGLDYRIVIATVDDGRRWVLRIPRRAEVSAKVEPEARVLAMLKNRLPFAVPDWRVANAELVAYPMLEDSTAMVIQPGSSTPDWVVPQDSEVFAESFATALAALHAVPISAAVDAGMLIRTPTQARQKVADDVDRVRREFVVNDKRLHRWQRWLDDDSSWPDFSVVVHGDLYVGHVLIDNTERVSGMIDWSEARVDDPAIDMAAHLMVFGEEGLAKLLLTYEAAGGRVWPRLAHHIAERLAFGAVTYALFALDSGNEEYLAAAKAQLAAAE	185.71	gnl|BL_ORD_ID|1170|hsp_num:0	1243		
BGC0000138.1|Rimocidin_10 # 16497 # 17843 # -1 # ID=1_10;partial=00;start_type=GTG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.686	BGC0000138.1|Rimocidin_10 	16497	17843	-	Loose	660	38.891	MexS	27.63	3000813	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGAAGGAAATACTGAACGCTATTCAGGCGCCGGACACCACGGCCGCCGACTTCGCCGCGCTGCCGCTGCCCGAGTCGTACCGCGCGATCACCGTCCACAAGGACGAGACCGACATGTTCGAGGGGCTCGCGGGGTGCGACAAGGACCCGCGCAAGTCGCTGCACCTCGACGAGGTGGCCGTCCCCGAACTCGGTCCCGGCGAGGCCCTGGTGGCCGTCATGGCGTCCTCGGTGAACTACAACAGCGTCTGGACCTCGATCTTCGAGCCGCTGCCGACGTTCGGGTTCCTGGAGCGGTACGGCCGGCGCAGCGAGCTCGCCAAGCGGCACGACCTGCCGTACCACGTCATCGGCTCCGACCTGGCGGGCGTCGTGCTGCGCACCGGGCCCGGCGTCACCGTCTGGAAGCCCGGTGACGAGGTCGTCGCGCACTGCCTGTCCGTCGAGCTGGAGAGCGCGGACGGCCACGGTGACACGATGCTCGACCCCGAGCAGCGCATCTGGGGCTTCGAGACCAATTTCGGCGGTCTCGCCGAACTCGCGCTGGTGAAGTCGAATCAGCTGATGCCCAAGCCCGGCCATCTCACGTGGGAGGAGGCGGCGGCCTCCGGGCTGGTGAATTCCACCGCGTACCGCCAGCTGGTGTCCCGCAACGGCGCGGGCATGAAGGTCGGTGACAATGTGCTGATCTGGGGCGCGAGCGGCGGACTCGGTTCGTACGCGACGCAGTTGGTGCTGGCCGGCGGCGGCACACCCGTCTGTGTGGTGTCCAACGACCAGAAGGCGGAGATCTGCCGGTCCATGGGCGCGGAAGCGGTCATCGACCGCAACGCCGAGGGGTACCGGTTCTGGAAGGACGAGCAGACGCAGGACCCCCGGGAGTGGAAGCGGTTCGGCAAGCGCATCCGCGAGCTGACCGGCGGCGAGGACGTGGACATCGTTTTCGAGCACCCGGGGCGGGAGACGTTCGGCGCGAGTGTGTTCGTCACGCGCAAGGGCGGCACGGTCGTCACCTGCGCCTCCACCTCGGGCTACCAGCACCAGTACGACAACCGCTATCTGTGGATGTCGCTCAAGCGCATCGTGGGCTCGCACTTCGCCAACTACCGCGAGGCGTGGGAGGCCAACCGCCTGATCGCCAAGGGCAGGATCCACCCGACGCTGTCCCAGACCTACCCCCTGAGGGAGACCGGGCAGGCGGCGTACGACGTGCACCGCAACCTCCACCAGGGCAAGGTCGGCATTCTGGCGCTCGCTCCCGAGGAAGGACTCGGCGTACGGGACGCCGAGTTCCGGGCGCGGCACGCCAGCGCCATCAACCGCTTCCGCGGGACGCTGGAGGACTGA	VKEILNAIQAPDTTAADFAALPLPESYRAITVHKDETDMFEGLAGCDKDPRKSLHLDEVAVPELGPGEALVAVMASSVNYNSVWTSIFEPLPTFGFLERYGRRSELAKRHDLPYHVIGSDLAGVVLRTGPGVTVWKPGDEVVAHCLSVELESADGHGDTMLDPEQRIWGFETNFGGLAELALVKSNQLMPKPGHLTWEEAAASGLVNSTAYRQLVSRNGAGMKVGDNVLIWGASGGLGSYATQLVLAGGGTPVCVVSNDQKAEICRSMGAEAVIDRNAEGYRFWKDEQTQDPREWKRFGKRIRELTGGEDVDIVFEHPGRETFGASVFVTRKGGTVVTCASTSGYQHQYDNRYLWMSLKRIVGSHFANYREAWEANRLIAKGRIHPTLSQTYPLRETGQAAYDVHRNLHQGKVGILALAPEEGLGVRDAEFRARHASAINRFRGTLED	MSRVIRFHQFGPPEVLKCEELPTPAPAAGEVLVRVQAIGVSWKDVLWRQNLAPEQAALPSGLGFELAGEVLAVGAGVGDLPLGSRVASFPAHTPDHYPAYGDVVLMPRAALAVYPEVLTPVEASVYYTGLLVAYFGLVDLAGLKAGQTVLITEAARMYGPVSIQLAKALGARVIASTKSAEEREFLREQGADKVVVTDEQDLVLEVERFTEGKGVNVILDELGGPQMTLLGDVSATRGKLVLYGCNGGNESAFPACAAFKKHLQFYRHCLMDFTGHPEMGLERNDESVSKALAHIEQLTRDRLLKPVVDRVFEFDQVVEAHRYMETCPKRGRVVIHVAD	132.15	gnl|BL_ORD_ID|1067|hsp_num:0	1041		
BGC0000138.1|Rimocidin_11 # 18149 # 18550 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.704	BGC0000138.1|Rimocidin_11 	18149	18550	-	Loose	300	33.4982	SAT-4	25.0	3002897	protein homolog model	n/a	n/a	nucleoside antibiotic	antibiotic inactivation	streptothricin acetyltransferase (SAT)	ATGGCGATCACGTACGAGTGGCGGGGCGACTTCGAGAACGCGGCCGTCAACCGGCTGCACGCGGAGGGCTTCGGCCACCGGGGCCTGGACATCGACTGGGTGGCGCAGGTCCACCGGCACAGTCTCGGCTGGGTGTGCGCCCGGCGCGACCGTGACGGTGAACTCGTCGGCTTCGTCAATGTCGCGTGGGACGGTGGTGTCCACGCGTTCGTCCTGGACACCGTGGTGACGGCGGACATGCGCCGTTCCGGGATCGGTGCCGGGCTGGTCGCCGCGGCCGTCGGGGGCGCCCGGGCGGCGCGGTGCGAATGGCTGCACGTCGACTTCGACGACGAACTGCGCACGTTCTACTTCGACGCCTGCGGGTTCCAGCCGACGAACGCGGGTCTCATCGCACTCTGA	MAITYEWRGDFENAAVNRLHAEGFGHRGLDIDWVAQVHRHSLGWVCARRDRDGELVGFVNVAWDGGVHAFVLDTVVTADMRRSGIGAGLVAAAVGGARAARCEWLHVDFDDELRTFYFDACGFQPTNAGLIAL	MITEMKAEHLKDIDKPSEPFEVIGKIIPRYENENWTFTELLYEAPYLKSYQDEEDEEDEEADCLEYIDNTDKIIYLYYQDDKCVGKVKLRKNWNRYAYIEDIAVCKDFRGQGIGSALINISIEWAKHKNLHGLMLETQDNNLIACKFYHNCGFKIGSVDTMLYANFENNFEKAVFWYLRF	73.89	gnl|BL_ORD_ID|1523|hsp_num:0	1505		
BGC0000138.1|Rimocidin_12 # 18593 # 19054 # 1 # ID=1_12;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.749	BGC0000138.1|Rimocidin_12 	18593	19054	+	Loose	2000	28.4906	adeJ	28.3	3000781	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; lincosamide antibiotic; carbapenem; cephalosporin; tetracycline antibiotic; rifamycin antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGTGCGCATGGCCGAGCTTGTCGCAACGTCCGTCGGTGGCACACCGATCACGGCCCTCGACGACGGCGAAGGACCGCCGCTGCTCCTCGTGCACGGGGGCGGTGGCGGCACCGCGTCCTGGGACGGCGTCATACGGTCGCTGGCCGACGGCTTCCGGGTGGTCAGGATCGCCCGCCGTATCTACGTCCCCGGGGCGACGACCCCGCCGTACTACTCGACGGCCGTCGAAGCGGCGGACATTCTGGCGATCGCCGGGCTCCTCGGCCGGCCCCCGCTGCTGGCCGGTCACTCCTCGGGCGCGGTCGCCGCGCTCGAAGCGGCGGTGCGTGCGCCCGAGGCACTGGCGGGCCTGTTCCTCTACGAACCGCCGGTGTCCACCCGGTCCCTGGCCGGAGGGGAGGCGGCCCGGCGCGCCCGTGCGGCGTTCGAGGCGGGAGACGCCCGCGAGGCGATGCGGATC	MVRMAELVATSVGGTPITALDDGEGPPLLLVHGGGGGTASWDGVIRSLADGFRVVRIARRIYVPGATTPPYYSTAVEAADILAIAGLLGRPPLLAGHSSGAVAALEAAVRAPEALAGLFLYEPPVSTRSLAGGEAARRARAAFEAGDAREAMRI	MAQFFIHRPIFAWVIALVIMLAGILTLTKMPIAQYPTIAPPTVTIAATYPGASAETVENTVTQIIEQQMNGLDGLRYISSNSAGNGQASIQLNFEQGVDPDIAQVQVQNKLQSATALLPEDVQRQGVTVTKSGASFLQVIAFYSPDNNLSDSDIKDYVNSSIKEPLSRVAGVGEVQVFGGSYAMRIWLDPAKLTSYQLTPSDIATALQAQNSQVAVGQLGGAPAVQGQVLNATVNAQSLLQTPEQFKNIFLKNTASGAEVRLKDVARVELGSDNYQFDSKFNGKPAAGLAIKIATGANALDTAEAVEQRLSELRKNYPTGLADKLAYDTTPFIRLSIESVVHTLIEAVILVFIVMFLFLQNWRATIIPTLAVPVVVLGTFAVINIFGFSINTLTMFAMVLAIGLLVDDAIVVVENVERVMSEDHTDPVTATSRSMQQISGALVGITSVLTAVFVPMAFFGGTTGVIYRQFSITLVTAMVLSLIVALTFTPALCATILKQHDPNKEPSNNIFARFFRSFNNGFDRMSHSYQNGVSRMLKGKIFSGVLYAVVVALLVFLFQKLPSSFLPEEDQGVVMTLVQLPPNATLDRTGKVIDTMTNFFMNEKDTVESIFTVSGFSFTGVGQNAGIGFVKLKDWSKRTTPETQIGSLIQRGMALNMIIKDASYVMPLQLPAMPELGVTAGFNLQLKDSSGQGHEKLIAARNTILGLASQDKRLVGVRPNGQEDTPQYQINVDQAQAGAMGVSIAEINNTMRIAWGGSYINDFVDRGRVKKVYVQGDAGSRMMPEDLNKWYVRNNKGEMVPFSAFATGEWTYGSPRLERYNGVSSVNIQGTPAPGVSSGDAMKAMEEIIGKLPSMGLQGFDYEWTGLSLEERESGAQAPFLYALSLLIVFLCLAALYESWSIPFSVLLVVPLGVIGAIVLTYLGMIIKGDPNLSNNIYFQVAIIAVIGLSAKNAILIVEFAKELQEKGEDLLDATLHAAKMRLRPIIMTTLAFGFGVLPLALSTGAGAGSQHSVGFGVLGGVLSATFLGIFFIPVFYVWIRSMFKYKPKTINTQEHKS	14.56	gnl|BL_ORD_ID|589|hsp_num:0	630		
